Form 10Q
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                   Quarterly Report Under Section 13 or 15 (d)
                     of the Securities Exchange Act of 1934

For Quarter Ended: May 31, 1999
Commission File Number: 0-11050

                              Mammatech Corporation
                              ---------------------
             (Exact name of registrant as specified in its charter)


            Florida                                            59-2181303
            -------                                            ----------
(State or other jurisdiction of                           (I.R.S. Employer
incorporation or organization)                            Identification Number)


930 N.W. 8th Avenue, Gainesville, Florida                        32601
-----------------------------------------                        -----
(Address of principal executive offices)                       (Zip Code)


                                 (352) 375-0607
                                 --------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past ninety days. Yes X  No_______

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:

                                                 Number of shares outstanding on

                                                            May 31, 1999
                                                            ------------
                                                   100,352,500 shares of which
                                                  7,408,500 are treasury shares
TITLE OF EACH CLASS
-------------------
Common stock $.0001 par value

The total number of pages of this report is 11


<PAGE>


                              Mammatech Corporation

                                      INDEX
--------------------------------------------------------------------------------

PART I.

     FINANCIAL INFORMATION                               PAGE NO.


         Item 1.  Financial Statements

         Statements of Operations for Three Months
         Ended May 31, 1999 and May 31, 1998....................3

         Balance Sheets for May 31, 1999
         August 31, 1998......................................4-5

         Statement of Cash Flow for the Quarter
         Ended May 31, 1999.....................................6

         Statements of Cash Flow for the Quarter
         Ended May 31, 1998.....................................7

         Notes to Financial Statements for the Quarter
         Ended May 31, 1999.....................................8


         Item 2.  Management's Discussion and Analysis of
         Financial Conditions and Results of Operations.........9


PART II.     OTHER INFORMATION


         Item 6.  Exhibits and Reports on Form 8-K.............10

         SIGNATURES........................................... 11





                                       -2-

<PAGE>
<TABLE>
<CAPTION>


                                  Mammatech Corporation
                                Statements of Operations
                                       (Unaudited)


                                 Nine Months Ended              Three Months Ended
                          ------------------------------   -----------------------------
                               May              May             May            May
                               1999             1998            1999           1998
                          -------------    -------------   -------------   -------------

<S>                       <C>              <C>             <C>             <C>
Sales, net                $     322,802          365,314   $     119,602         142,835

Cost of sales                   104,828          103,020          32,009          38,886
                          -------------    -------------   -------------   -------------

Gross Profit                    217,974          262,294          87,593         103,949
 Selling, general
and adminstra-
tive expense              $     302,087          226,016         104,981         133,303
                          -------------    -------------   -------------   -------------


Operating Income (Loss)         (84,113)          36,278         (17,388)         29,354
                          -------------    -------------   -------------   -------------

Other income
(expense)
 Interest &
 Dividend Income                 17,756           13,063           4,939           4,564

 SBIR Grant. reimb              133,071          103,088          43,526          37,697

Utilization of oper.
loss carryforward                   -0-              -0-             -0-             -0-


Net income before
   taxes                         66,714          152,429          31,077          12,907
Provision for income
   tax                              -0-              -0-             -0-             -0-


NET INCOME (LOSS)                66,714          152,429          31,077          12,907
                          -------------    -------------   -------------   -------------

Net income (loss)
per share                           .01              .01             .00             .00
                          =============    =============   =============   =============
  Weighted
average shares              100,352,500      100,352,500     100,352,500     100,352,500
                          =============    =============   =============   =============


The accompanying notes are an integral part of the financial statements.


                                           -3-

</TABLE>
<PAGE>

                              Mammatech Corporation

                                 Balance Sheets

                                                  May 31, 1999     Aug. 31, 1998
                                                  (Unaudited)         (Audited)
                                                  -----------         ---------

ASSETS
------

  Cash and Cash Equivalents                         $433,013          342,740
    Marketable Securities                            106,445           94,377

  Accounts receivable:
    Trade                                             55,192           74,983
    Other                                              3,218            3,190


  Inventory                                          207,713          201,574
   Other current assets                                 --               --

  Total Current Assets                               805,581          716,864

Property and equipment                                35,443           43,622

Other assets:


  Patents, trademarks, and
    other intangibles, net of
    accumulated amortization
    of $53,080 and $46,942
    respectively                                       7,392            8,657
                                                    --------         --------

             Total other assets                        7,392            8,657
                                                    --------         --------

TOTAL ASSETS                                        $848,416         $769,143



The accompanying notes are an integral part of the financial statements.


                                       -4-

<PAGE>

                              Mammatech Corporation
                                 Balance Sheets
                              As of August 31, 1998
                                and May 31, 1999
                                   (continued)


                                                     May 1999         Aug 1998
                                                     --------         --------

LIABILITIES AND STOCKHOLDERS' EQUITY
------------------------------------

CURRENT LIABILITIES
-------------------
Accounts payable-trade                             $    42,397      $    48,595
Accrued payable-officer                                  6,630            6,630
Short term debt                                          4,796            4,796
Accrued expenses                                       172,072          163,996
                                                   -----------      -----------

TOTAL CURRENT LIABILITIES                              225,895          223,987


COMMITMENTS
 Long term dept                                          1,940            1,940

Stockholders' equity:

  Common stock, par value $.0001;
  200,000,000 shares authorized;
  80,352,500 shares issued
  and outstanding                                  $    10,035      $    10,035

  Additional paid-in capital                         2,809,594        2,809,594
  Accumulated deficit                               (2,063,064)      (2,109,926)
                                                   -----------      -----------
                                                       756,565          709,703

  Valuation allowance for
    marketable securities                               12,068          (18,436)

  Treasury stock at cost,
  7,408,500 shares                                    (148,051)        (148,051)
                                                   -----------      -----------
                                                       620,582          543,216



TOTAL LIABILITIES AND                              $   848,417      $   769,143
STOCKHOLDERS' EQUITY


The accompanying notes are an integral part of these statements.


                                       -5-

<PAGE>


                              Mammatech Corporation
                             Statement of Cash Flow
                           For the Nine Months Ending
                                  May 31, 1999




Net cash flow from operating activities                                 $ 85,614
                                                                        ========

Investing Activities:
         Sale of certificate of deposit                                      -0-
         Purchase of furniture and fixtures                                4,659


Financing activities:



Net increase (decrease) in cash                                           90,273

Beginning cash                                                           342,740
                                                                        --------

Ending cash                                                             $433,013
                                                                        ========



                                       -6-

<PAGE>

                              Mammatech Corporation
                             Statement of Cash Flow
                           For the Nine Months Ending
                                  May 31, 1998




Net cash flow from operating activities                                   99,524
                                                                        ========

Investing Activities:
Sale of certificate of deposit                                               -0-
Purchase of furniture and fixtures                                         5,527


Financing activities:



Net increase (decrease) in cash                                          105,051

Beginning cash                                                           169,088
                                                                        --------

Ending cash                                                             $274,139
                                                                        ========





                                       -7-

<PAGE>


                             Mammatech Corporation
                         Notes to Financial Statements
                                  May 31, 1999


Note 1.   In the opinion of the Company,  the accompanying  unaudited  financial
          statements   contain  all  adjustments   (consisting  of  only  normal
          recurring accruals) necessary to present fairly the financial position
          as of May 31,  1999,  and the  results of  operations  and  changes in
          financial position for the three months ended May 31, 1999.


Note 2.   Loss per  share is based on the  weighted  average  number  of  shares
          outstanding during each period.



                                       -8-

<PAGE>

                MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
          CONDITIONS AND RESULTS OF OPERATION FOR MAMMATECH CORPORATION

Results for the third quarter of Fiscal 1999 were mixed.  Sales were up 77% over
the previous  quarter but were 16.2% less than sales during the third quarter of
1998. The operating loss of $17,388  reflects a decrease of 58% from the loss of
the previous  quarter but does not compare  favorably with the operating gain of
$29,354  posted in the third quarter of 1998.The  operating  loss is largely the
result of  expense  due to the SBIR  grant  that is not  offset  by sales.  When
reimbursement is included,  the net income of $31,101 compares  favorably to the
loss of $2,991 for the  previous  quarter  and is 141%  greater  than the figure
reported for the third quarter of 1998.

The nine month  figures  show an 11.6%  decrease in sales for the  current  year
compared to last year and a substantial decline in both operating income and net
income  with the latter  decreasing  by 56.2%.  The  decline in sales is largely
responsible for this outcome.

During the quarter,  the Company  intensified its training efforts and graduated
eleven new MammaCare Specialists.  Additionally,  the Company was represented by
its two  Training  Directors  at the  Ninth  Annual  Breast  Center  Development
Conference  organized by the National  Consortium of Breast  Centers,  Inc. This
exposure  generated a large number of  potential  contacts  which are  presently
being developed as customers for the training program.  Of course,  there can be
no  assurance  that such  trainings  will  materialize  or that any  significant
revenue with result.

The Company also  entered into a  collaborative  relationship  with  Multi-Media
Systems, Inc. of Rockville,  Md. to adapt the Company=s  proprietary  technology
for teaching and performing  clinical breast  examination (CBE) to the automated
training  technology  being developed by Multi-Media with the support of an SBIR
Phase II grant.  Revenue to the Company will be in the form of  consulting  fees
and a small amount of product sales. In the event the eventual technology proves
effective,  the  Company  is  prepared  to enter a  marketing  and  distribution
agreement  with  Multi-Media  such that the  technology  will be included in the
package offered to breast centers and medical training facilities.  Again, there
can be no  assurance  that  any  effective  technology  will  result  from  this
collaboration or that, even if it does, there will be any substantial  financial
benefit therefrom to the Company.

Finally, the Company has entered preliminary discussions with an organization in
Mexico aimed at distributing the Spanish versions of MammaCare  products in that
country.  It is too early to  forecast  the  success  of this  venture,  but the
Company is eager to extend its technology to this population.


The  Company  remains  essentially  debt-free  and  has no  immediate  liquidity
problems. It continues to search for other corporate affiliations that will help
it realize the full commercial potential of its products.


                                       -9-
<PAGE>


                           PART II - OTHER INFORMATION
                           ---------------------------



Item 6. Exhibits and Reports on Form 8-K

     (a.) Exhibits - None

     (b.) There were no reports filed on Form 8-K during the three months ending
          May 31, 1999.



                                      -10-

<PAGE>

                                      10-Q

                     For the three months ended May 31, 1999

                                   Signatures

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

MAMMATECH CORPORATION

DATE: July 13, 1999                        BY: /s/ Henry S. Pennypacker
     -----------------------------         -------------------------------------
                                           Henry S. Pennypacker, President
                                           and Director

BY: /s/ Mary Sellers
   -------------------------------
   Mary Sellers, Treasurer and
   Chief Financial Officer



                                      -11-